Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment

Hossein Jadvar, Leslie Ballas, Peter L. Choyke, Stefano Fanti, James L. Gulley, Ken Herrmann, Thomas A. Hope, Alan Klitzke, Jorge D. Oldan, Martin G. Pomper,

Journal of Nuclear Medicine · 2020 · 12 citations · 83 references

DOIFull text

Open access

Concepts

Abstract

Imaging is often used to evaluate men with biochemical recurrence (BCR) of prostate cancer after definitive primary treatment (radical prostatectomy [RP] or radiotherapy [RT]). The goal of imaging is to identify the source of elevated or rising serum prostate-specific antigen (PSA) levels because

References

83